Sweden to cover Voxzogo treatment for children with achondroplasia from November 1
As of November 1, a drug for short stature will be covered by the high-cost protection scheme, Dagens Medicin reports.
Sweden
Not just war: Nine things to look forward to in 2024
2024 was marked by war, misery, and brutal death. But there were glimmers of light. The world can, among other things, rejoice over promising treatments for severe diseases, freed human rights activists, and strengthened LGBTQ rights in several places. Here are nine positive news stories from the past year, listed in no particular order.
Conflicts
Not just war: Nine things to look forward to in 2024
2024 was marked by war, misery, and brutal death. But there were glimmers of light. The world can, among other things, rejoice in promising treatments for severe diseases, freed human rights activists, and strengthened LGBTQ rights in several places. Here are nine positive news stories from the past year, listed in no particular order.
Conflicts
The UK Approves Alzheimer's Medication
Despite a no in July from the European Medicines Agency EMA, the drug Leqembi is now approved for treatment of Alzheimer's patients in the United Kingdom.
BusinessTop news
Medicine Stop a Hard Blow for Alzheimer's Patients
The disappointment is great since a new drug against Alzheimer's has been rejected by the EU's pharmaceutical authority. It is outrageous, says Liselotte Jansson at the Alzheimer's Foundation.
Sweden
Upwards on Wall Street – major companies recovered
The trading week on Wall Street ended in major, after many large technology companies had a shaky week.
Business
Alzheimer's drug rejected by EMA
The Alzheimer's drug lecanemab has not been approved by the European Medicines Agency EMA. The benefits are not considered to outweigh the potential drawbacks. A review of the decision will be requested, announces Swedish Bioarctic – whose share plummeted on the news.
Sweden